Statins in the prevention of transplant coronary artery disease: In pediatric heart recipients

被引：5

作者：

Pahl, Elfriede ^{[1
]}

机构：

[1] Childrens Mem Hosp, Feinberg NW Sch Med, Heart Transplant Program, Chicago, IL 60614 USA

来源：

PEDIATRIC TRANSPLANTATION | 2007年 / 11卷 / 05期

关键词：

D O I：

10.1111/j.1399-3046.2007.00710.x

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：459 / 460

页数：2

共 13 条

[1] Effect of age on lipid profiles in pediatric heart transplant recipients [J].

Armstrong, AK ;

Goldberg, CS ;

Crowley, DC ;

Wei, W ;

Gajarski, RJ .

PEDIATRIC TRANSPLANTATION, 2005, 9 (04) :523-530

[2]

Chin C, 2000, Pediatr Transplant, V4, P193, DOI 10.1034/j.1399-3046.2000.00112.x

[3] Efficacy and safety of atorvastatin after pediatric heart transplantation [J].

Chin, C ;

Gamberg, P ;

Miller, J ;

Luikart, H ;

Bernstein, D .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (11) :1213-1217

[4] Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy [J].

Hedman, Mia ;

Pahlman, Raija ;

Sundvall, Jouko ;

Ehnholm, Christian ;

Syvanne, Mikko ;

Jokinen, Eero ;

Jauhiainen, Matti ;

Holmberg, Christer ;

Antikainen, Marjatta .

PEDIATRIC TRANSPLANTATION, 2007, 11 (05) :481-490

[5] Ten-year follow-up of a randomized-trial of pravastatin in heart transplant patients [J].

Kobashigawa, JA ;

Moriguchi, JD ;

Laks, H ;

Wener, L ;

Hage, A ;

Hamilton, MA ;

Cogert, G ;

Marquez, A ;

Vassilakis, ME ;

Patel, J ;

Yeatman, L .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11) :1736-1740

[6] EFFECT OF PRAVASTATIN ON OUTCOMES AFTER CARDIAC TRANSPLANTATION [J].

KOBASHIGAWA, JA ;

KATZNELSON, S ;

LAKS, H ;

JOHNSON, JA ;

YEATMAN, L ;

WANG, XM ;

CHIA, D ;

TERASAKI, PI ;

SABAD, A ;

COGERT, GA ;

TROSIAN, K ;

HAMILTON, MA ;

MORIGUCHI, JD ;

KAWATA, N ;

HAGE, A ;

DRINKWATER, DC ;

STEVENSON, LW .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (10) :621-627

[7] Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens [J].

Law, YM ;

Yim, R ;

Agatisa, P ;

Boyle, GJ ;

Miller, SA ;

Lawrence, K ;

Webber, SA .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (03) :276-282

[8] Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation [J].

Mahle, WT ;

Vincent, RN ;

Berg, AM ;

Kanter, KR .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (01) :63-66

[9] The impact and outcome of transplant coronary artery disease in a pediatric population: A 9-year multi-institutional study [J].

Pahl, E ;

Naftel, DC ;

Kuhn, MA ;

Shaddy, RE ;

Morrow, WR ;

Canter, CE ;

Kirklin, J .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (06) :645-651

[10] Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients [J].

Penson, MG ;

Fricker, FJ ;

Thompson, JR ;

Harker, K ;

Williams, BJ ;

Kahler, DA ;

Schowengerdt, KO .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (06) :611-618

← 1 2 →